Symbols

ALC

Alcon·NYSE

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 3

Ample Liquidity

High Gross Profit Margin

High Cash/net Profit Ratio

Bearish Abandoned Baby

EPS Below Expectations

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ALC

Alcon Inc.

A global leader in eye care that offers a full suite of eye care products

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

04/09/2019

Exchange

New York Stock Exchange

Full-time Employees

25,942

Fiscal Year Ends

12-31

Website

www.alcon.com

Security Type

Common stock

Office address

Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland

Business

Development, production and sale of pharmaceuticals, surgical equipment and equipment, and consumer eye care products

Introduction

Alcon Inc., originally founded in 1945, was founded by pharmacists Robert Alexander and William Conner, who opened a small pharmacy under the name "Alcon" in Fort Worth, Texas. In 1947, Alcon was first registered and established, and began to manufacture professional pharmaceutical products to meet the needs of eye health. Alcon is a global leader in eye care. They research, develop, manufacture, distribute and sell a full range of eye care products within two key businesses: surgery and vision care. Their surgical business focuses on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. In addition to their world-class products, Alcon also provides customers with first-class service, training, education and technical support.

Company Financials

EPS

ALC has released its 2025 Q4 earnings. EPS was reported at 0.78, versus the expected 0.78, meeting expectations. The chart below visualizes how ALC has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ALC has released its 2025 Q4 earnings report, with revenue of 2.72B, reflecting a YoY change of 8.63%, and net profit of 217.00M, showing a YoY change of -23.59%. The Sankey diagram below clearly presents ALC's revenue sources and cost distribution.